VistaGen Therapeutics (NASDAQ:VTGN) Downgraded by Zacks Investment Research to Hold

VistaGen Therapeutics} stock has undergone multiple analysts rating changes in the recent past.  VistaGen Therapeutics Downgraded by Zacks Investment Research on 10/14/2021. In a note to investors, the firm issued a new rating of Hold. The analysts previously had rating of Buy.

View More VistaGen Therapeutics (NASDAQ:VTGN) Downgraded by Zacks Investment Research to Hold

Analysts Estimate Report : What to Look Out for NASDAQ:OBCI, NASDAQ:PFMT, NASDAQ:FREQ, NASDAQ:VTGN

Quarterly, annual earnings. See the latest EPS estimates vs Actual and surprise it caused. Stock Market Daily has their analysis…

View More Analysts Estimate Report : What to Look Out for NASDAQ:OBCI, NASDAQ:PFMT, NASDAQ:FREQ, NASDAQ:VTGN

Reports Strong First-Quarter Financial Results VistaGen Therapeutics (NASDAQ:VTGN)

Earnings results for VistaGen Therapeutics , Analyst Opinion on VistaGen Therapeutics , Earnings and Valuation of (NASDAQ:VTGN), Stock market Insights & financial analysis, Best stock to invest, Investment Idea,

View More Reports Strong First-Quarter Financial Results VistaGen Therapeutics (NASDAQ:VTGN)

Earnings Report: Here’s what to expect from VistaGen Therapeutics (NASDAQ:VTGN)

Earnings results for VistaGen Therapeutics , Analyst Opinion on VistaGen Therapeutics , Earnings and Valuation of (NASDAQ:VTGN), Stock market Insights & financial analysis, Best stock to invest, Investment Idea,

View More Earnings Report: Here’s what to expect from VistaGen Therapeutics (NASDAQ:VTGN)

Factors Likely to Have Influenced Earnings Results VistaGen Therapeutics (NASDAQ:VTGN)

Earnings results for VistaGen Therapeutics , Analyst Opinion on VistaGen Therapeutics , Earnings and Valuation of (NASDAQ:VTGN), Stock market Insights & financial analysis, Best stock to invest, Investment Idea,

View More Factors Likely to Have Influenced Earnings Results VistaGen Therapeutics (NASDAQ:VTGN)

Is it time to Buy before this week’s earning report VistaGen Therapeutics (NASDAQ:VTGN)

Earnings results for VistaGen Therapeutics , Analyst Opinion on VistaGen Therapeutics , Earnings and Valuation of (NASDAQ:VTGN), Stock market Insights & financial analysis, Best stock to invest, Investment Idea,

View More Is it time to Buy before this week’s earning report VistaGen Therapeutics (NASDAQ:VTGN)